Dibucaine
NDC 71399-2829, Dibucaine, ointment, from Akron Pharma Inc..
- Product NDC
- 71399-2829
- Status
- Listed
- Labeler
- Akron Pharma Inc.
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M015
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71399-2829 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIBUCAINE.28 g/28g
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71399-2829-1 | 71399282901 | 28 g in 1 TUBE (71399-2829-1) |
| 71399-2829-2 | 71399282902 | 1 TUBE in 1 PACKAGE (71399-2829-2) / 56 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 71399-2829 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71399-2829 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71399-2829. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.